祥生醫療(688358.SH):網上搖號中籤號碼共15240個 國金創新投資獲配80萬股
格隆匯11月24日丨祥生醫療(688358.SH)發佈首次公開發行股票並在科創板上市網下初步配售結果及網上中籤結果公告,具體如下:
網上搖號中籤結果:
凡在網上申購祥生醫療首次公開發行A股股票的投資者持有的申購配號尾數與上述號碼相同的,則為中籤號碼。中籤號碼共有15240個,每個中籤號碼只能認購500股祥生醫療A股股票。


網下發行申購情況及初步配售結果:
此次發行的網下申購工作已於2019年11月21日結束。經核查確認,《發行公告》披露的270家網下投資者管理的3074個有效報價配售對象數量全部按照《發行公告》的要求進行了網下申購,網下有效申購數量為755,690萬股。


其中零股690股按照《發行安排及初步詢價公告》中的網下配售原則配售給同泰基金管理有限公司管理的“同泰開泰混合型證券投資基金”。
發行人與保薦機構(主承銷商)定於2019年11月26日上午在上海市浦東東方路778號紫金山大酒店四樓會議室海棠廳進行此次發行網下限售賬户的搖號抽籤,並將於2019年11月27日披露網下限售賬户搖號中籤結果。
戰略配售最終結果:
經確認,《發行公告》中披露的保薦機構相關子公司跟投參與此次發行戰略配售有效。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.